Chris W.

Chris W. has a wealth of work experience in the life sciences field. In 2018, they founded Sercader, a commercial advisory and execution company in life sciences. In 2019, they became the Chief Business Officer of MGB Biopharma Limited, and also took on the role of Non-Executive Director of Altair Medical. In 2020, they were appointed Non-Executive Director of Lamellar Biomedical and also became a Senior Advisor and Chief Operating Officer at Clyde Biosciences. Additionally, they were a Global Commercial Partnering at Quintiles from 2011-2020 and a Global Strategic Planning & Business Development at ProStrakan from 2002-2011. In 2021, they became a Board Member of the Scottish Poetry Library, and has been a GlobalScot Member since 2009.

Chris W. attended Durham University from 1988 to 1991, where they received a BA (Hons) in Archaeology. Chris then attended Alliance Manchester Business School from 1998 to 2003, where they received an MBA in Finance. In 2004, they attended Harvard Business School to study Leadership and Strategy in Pharmaceuticals and Biotech.